Susan Dent

Dr Dent attended McMaster University Medical School in Hamilton, Ontario, Canada and completed her residency training in Internal Medicine and Medical Oncology at the Ottawa Hospital, University of Ottawa, Ontario, Canada. She subsequently completed a post graduate research fellowship in clinical trials at the Canadian Cancer Trials Group (CCTG) in Kingston, Ontario, and was appointed as a staff medical in Thunder Bay, Ontario.

In 2001, Dr Dent returned to Ottawa, where she specialised in the treatment of breast cancer with a focus on new drug development. In 2008, Dr. Dent, she established a multidisciplinary cardio-oncology clinic in Ottawa and in 2011, she founded the Canadian Cardiac Oncology Network (CONN), a not-for-profit organisation devoted to optimisation of cancer care for patients without compromising cardiovascular health. In 2015, Dr. Dent launched the Global Cardio-Oncology Summit (GCOS), an annual meeting which now attracts oncologists, cardiologists, and allied health care providers from more than 23 countries. Dr. Dent held a staff position at Duke from 2018-2024 as Associate Director of Breast Cancer Clinical research and Co-Director of the Duke Cardio-Oncology program.

Dr Dent is recognised for her efforts in the evaluation of novel cancer treatments for breast cancer while gaining a better understanding of the impact of these treatments on cardiovascular health.  She is recognised as a global leader in cardio-oncology. She has travelled extensively around the world sharing her knowledge and expertise on cancer therapy related cardiovascular toxicity.  She continues to work and build relationships with global organisations interested in cardio-oncology including: European Society of Medical Oncology, American College of Cardiology, the American Heart Association, and the European Society of Cardiology and the American Society of Clinical Oncology. Dr. Dent currently serves as President of the International Cardio-Oncology society (ICOS), an organisation dedicated to bringing cardiologists, oncologists, and allied health care providers together, to improve the clinical care of patients and save lives. 

In September 2024, Dr. Dent accepted a staff position at the University of Rochester, New York, as a breast cancer medical oncologist, Director of Cardio-Oncology, and Director of Survivorship at the Wilmot Cancer Institute.